MedTrace Logo

Gut Microbiota is Associated With Autoimmune Thyroid Disease

NCT03390582 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2018-01-04

No results posted yet for this study

Summary

Autoimmune thyroid disease (AITD), which includes Hashimoto's thyroiditis (HT) and Grave's disease (GD), are the most common organ-specific autoimmune diseases and affect more women than men, with a female-to-male ratio from 5 to 10. Many studies have indicated that alterations in the gut microbiota are important environmental factors in the development of inflammatory and autoimmune diseases. Investigators systematically performed a comparative analysis of the gut microbiota in AITD patients and healthy controls.

Conditions

  • Gut Microbiota

Interventions

DRUG

Methimazole Pill

Hyperthyroidism patients are treated with Methimazole Pill according to the guidelines

Sponsors & Collaborators

  • First Affiliated Hospital of Harbin Medical University

    lead OTHER

Principal Investigators

  • Wei Yunwei · First Affiliated Hospital of Harbin Medical University

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-04-20
Primary Completion
2018-12-24
Completion
2021-11-01
FDA Drug
Yes

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03390582 on ClinicalTrials.gov